The expression of CD39 on circulating Sezary cells is genetically controlled

被引：0
|
作者：
Picozza, M. [1 ]
Caprini, E. [2 ]
Cristofoletti, C. [2 ]
Bresin, A. [2 ]
Monopoli, A. [2 ]
Borsellino, G. [1 ]
Russo, G. [2 ]
Narducci, M. G. [2 ]
机构：
[1] Fdn Santa Lucia, Lab Neuroimmunol, I-00143 Rome, Italy
[2] IRCCS, IDI, Lab Mol Oncol, I-00167 Rome, Italy
来源：
EUROPEAN JOURNAL OF CANCER | 2019年 / 119卷
关键词：
D O I：
10.1016/S0959-8049(19)30629-X
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
119
引用
收藏
页码：S43 / S43
页数：1
相关论文
共 50 条
  • [41] Flow-cytometry and functional evaluation of the CD39/CD73 adenosinergic immunosuppressive axis in patients with Sezary syndrome
    Quaglino, Pietro
    Funaro, Ada
    Ortolan, Erika
    Senetta, Rebecca
    Avallone, Gianluca
    Merli, Martina
    Bracci, Cristiano
    Rumore, Maria Rebecca
    Yakymiv, Yuliya
    Fierro, Maria Teresa
    EUROPEAN JOURNAL OF CANCER, 2021, 156 : S12 - S13
  • [42] CD39/CD73 dysregulation and adenosine metabolism contribute to T-cell immunosuppression in patients with Sezary syndrome
    Yakymiv, Yuliya
    Marchisio, Sara
    Ortolan, Erika
    Bracci, Cristiano
    Senetta, Rebecca
    Rumore, Maria Rebecca
    Tampieri, Cristian
    Fia, Marianna
    Ribero, Simone
    Funaro, Ada
    Quaglino, Pietro
    BLOOD, 2023, 141 (01) : 111 - 116
  • [43] Low expression of CD39 and CD73 genes in centenarians compared with octogenarians
    Crooke, Almudena
    Martinez-Henandez, Juan
    Martinez-Lopez, Joaquin
    Cruz-Jentoft, Alfonso
    Huete-Toral, Fernando
    Pintor, Jesus
    IMMUNITY & AGEING, 2017, 14
  • [44] Exploring CD39 and CD73 Expression as Potential Biomarkers in Prostate Cancer
    Gardani, Carla Fernanda Furtado
    Pedrazza, Eduardo Luiz
    Paz, Victoria Santos
    Zanirati, Gabriele Goulart
    da Costa, Jaderson Costa
    Andrejew, Roberta
    Ulrich, Henning
    Scholl, Juliete Nathali
    Figueiro, Fabricio
    Rockenbach, Liliana
    Morrone, Fernanda Bueno
    PHARMACEUTICALS, 2023, 16 (11)
  • [45] Isolated CD39 Expression on CD4+T Cells Denotes Both Regulatory and Memory Populations.
    Zhou, Qiang
    Putheti, Prabhakar
    Wu, Yan
    Kassam, Nasim
    Enjyoji, Keiichii
    Robson, Simon C.
    Strom, Terry B.
    Gao, Wenda
    AMERICAN JOURNAL OF TRANSPLANTATION, 2009, 9 : 537 - 537
  • [46] The aberrant expression of CD39 is associated with the dismal outcome of patients with cholangiocarcinoma
    Bohao Zheng
    Sheng Shen
    Jiwen Wang
    Wentao Sun
    Wenze Wan
    Jiaying Liu
    Dexiang Zhang
    Xiaoling Ni
    Tao Suo
    Han Liu
    Xiaojian Ni
    Houbao Liu
    Clinical Cancer Bulletin, 4 (1):
  • [47] Low expression of CD39 and CD73 genes in centenarians compared with octogenarians
    Almudena Crooke
    Juan Martínez-Henández
    Joaquín Martínez-López
    Alfonso Cruz-Jentoft
    Fernando Huete-Toral
    Jesús Pintor
    Immunity & Ageing, 14
  • [48] Association of aberrant expression of CD39 with the outcome of patients with cholangiocarcinoma.
    Zheng, Bohao
    Ni, Xiaojian
    Liu, Houbao
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (23_SUPPL) : 93 - 93
  • [49] Expression of Human CD39 Protects in a Liver Transplant Model.
    Pommey, Sandra
    Lu, Bo
    Robson, Simon
    d'Apice, Tony
    Cowan, Peter
    Dwyer, Karen
    AMERICAN JOURNAL OF TRANSPLANTATION, 2010, 10 : 167 - 167
  • [50] Enhanced expression of CD39 and CD73 on T cells in the regulation of anti-tumor immune responses
    Shevchenko, Ivan
    Mathes, Andreas
    Groth, Christopher
    Karakhanova, Svetlana
    Mueller, Verena
    Utikal, Jochen
    Werner, Jens
    Bazhin, Alexandr V.
    Umansky, Viktor
    ONCOIMMUNOLOGY, 2020, 9 (01):
12345